Specialty Pharmaceuticals Company Salix Pharmaceuticals is committed to providing treatments for a wide spectrum of gastrointestinal disorders.

Genmab, a top big biotech company, headquartered in Denmark is one of the leaders today in the human antibody therapeutics market for cancer treatment.

Salix Pharmaceuticals has announced 3 M&A deals since 2009, with the deals being the acquisition of Santarus, Oceana Therapeutics and the merger between Salix and Cosmo Pharmaceuticals.

MorphoSys, a leader in antibody drug discovery, has emerged as a top 50 big biotech company with its product pipeline and partnering strategy.

Genmab is an internationally recognised biotechnology company developing human antibody therapeutics primarily for cancer.

Isis Pharmaceuticals, a leader in antisense drug discovery, has emerged as a top 50 big biotech company with its business strategy.

MorphoSys has announced only one acquisition in the past 5 years.

Headquartered in Dublin, Ireland Jazz Pharmaceuticals is a specialty biopharmaceuticals company that has undergone significant growth in recent years. Jazz Pharmaceuticals is focused upon delivering products for cataplexy, narcolepsy, oncology/leukemia, chronic pain and non-opioid schizophrenia.  

Isis Pharmaceuticals is an antisense drug discovery technology company developing therapies for a number of serious diseases.

Jazz Pharmaceuticals, listed as a new big biotech entrant in 2014, has announced 3 M&A deals since 2009, with the lead deals being the acquisitions of Gentium and merger with Azur Pharma.